Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Digoxin for CTC Clusters in Advanced Breast Cancer
NCT03928210Phase 1Completed
- Sponsor
- University Hospital Basel
- Start
- Jul 2020
- Primary completion
- Dec 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of digoxin in breast cancer, sponsored by University Hospital Basel. Primary endpoint: Change in mean CTC cluster size at Day 21. Started Jul 2020; status: completed.
02
Drugs
digoxin
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT03928210.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03928210.